Used primarily in organic synthesis, this compound serves as a key intermediate in the preparation of various pharmaceuticals, particularly those targeting central nervous system disorders. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds in complex molecules. Additionally, it is employed in the development of PET (positron emission tomography) imaging agents, aiding in the diagnosis and study of neurological conditions. The trifluoromethyl group enhances its metabolic stability, making it suitable for drug candidates with improved pharmacokinetic properties.